Hot shot: the wider promise of weight-loss ja...

An ousted former opposition leader started a new party—called the New Party. We assess its chances at the ballot box, and under President Recep Tayyip Erdogan’s thumb. A surrogacy scandal in Germany has prompted a government reshuffle, with Chancellor Friedrich Merz left holding ...  Show more

Wildfires in France and Spain are only growing worse by the day. We examine what can be done as a future of more fires, and worse ones, becomes more assured. A dig into data on women at work shows several indicators starting to move in the wrong direction. And the American cities ...  Show more

Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ...  Show more

What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ...  Show more

Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ...  Show more

The Trump administration is making GLP-1s more affordable. This class of drugs seems to have forever changed the game on diet and exercise for Americans. This episode was produced by Miles Bryan, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Patrick Boyd and ...  Show more